These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2974108)

  • 1. [Progressive symmetric erythrokeratodermia. Report of a case with delayed onset treated by etretinate].
    Borbujo Martinez J; Casado Jimenez M; Jimenez Acosta F; Almagro Sanchez M; Martinez Gomez W; Soto Melo J
    Med Cutan Ibero Lat Am; 1988; 16(3):236-8. PubMed ID: 2974108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of erythrokeratodermia figurata variabilis successfully treated with tigason].
    Magyarlaki M; Drobnitsch I; Zombai E; Schneider I
    Z Hautkr; 1989 Oct; 64(10):881-2, 885-7. PubMed ID: 2531508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrokeratodermia variabilis: immunohistochemical and ultrastructural studies of the epidermis.
    McFadden N; Oppedal BR; Ree K; Brandtzaeg P
    Acta Derm Venereol; 1987; 67(4):284-8. PubMed ID: 2445144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mendes Da Costa erythrokeratoderma variabilis. Effect of RO 10-9359 (Tigason)].
    Larrègue M; Bressieux JM; Titi A; De Voel G; Bieder C; Lhuillier N; Bachour I
    Ann Dermatol Venereol; 1988; 115(11):1123-5. PubMed ID: 2977072
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive symmetric erythrokeratodermia. Histological and ultrastructural study of patient before and after treatment with etretinate.
    Nazzaro V; Blanchet-Bardon C
    Arch Dermatol; 1986 Apr; 122(4):434-40. PubMed ID: 2937369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eruptive seborrheic keratoses associated with erythrodermic pityriasis rubra pilaris. Possible role of retinoid therapy.
    Schwengle LE; Rampen FH
    Acta Derm Venereol; 1988; 68(5):443-5. PubMed ID: 2461032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Langerhans cells in erythrokeratodermia variabilis. Histochemical and ultrastructural investigations before and after treatment with etretinate (RO 10-9359).
    van der Schroeff JG; Ruiter DJ; Bots GT
    Arch Dermatol Res; 1982; 274(3-4):339-48. PubMed ID: 6187301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma.
    Tamayo L; Ruiz-Maldonado R
    Dermatologica; 1980; 161(5):305-14. PubMed ID: 6449393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tigason in hyperkeratosis lenticularis perstans (HLP)--a case report].
    Gabrielsen TO
    Z Hautkr; 1986 Feb; 61(4):214-7. PubMed ID: 3962407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of a new retinoid, Ro 12-7554, in psoriasis and in some congenital disorders of keratinization.
    Ott F; Bounameaux Y
    Dermatologica; 1983; 167(1):52-3. PubMed ID: 6226548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the use of Ro 10-9359 (Tigason) in children justified?
    van der Rhee HJ; van Gelderen HH; Polano MK
    Acta Derm Venereol; 1980; 60(3):274-5. PubMed ID: 6158237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythrokeratodermia anularis migrans--a new genetic dermatosis?].
    Vakilzadeh F; Rose I
    Hautarzt; 1991 Oct; 42(10):634-7. PubMed ID: 1836783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Crocodile baby", a non-fatal form of malignant keratoma?].
    Masouyé I; Harms M; Saurat JH
    Ann Dermatol Venereol; 1988; 115(3):311-5. PubMed ID: 2970240
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progressive and symmetrical erythrokeratoderma of Darier-Gottron].
    Dupertuis MC; Laroche L; Huault MC; Blanchet-Bardon C
    Ann Dermatol Venereol; 1991; 118(11):775-8. PubMed ID: 1838672
    [No Abstract]   [Full Text] [Related]  

  • 16. Etretinate-induced skeletal muscle damage.
    Hodak E; David M; Gadoth N; Sandbank M
    Br J Dermatol; 1987 May; 116(5):623-6. PubMed ID: 2954577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of erythrokeratodermia variabilis with oral synthetic retinoids.
    Fixler ZC
    Cutis; 1980 Mar; 25(3):300-4. PubMed ID: 6444572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of superficial disseminated actinic porokeratosis treated with an aromatic retinoid].
    Ludera-Zimoch G; Rubisz-Brzezińska J
    Przegl Dermatol; 1989; 76(1):54-7. PubMed ID: 2813819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid acid in the treatment of hyperkeratosis lenticularis perstans Flegel.
    Lindemayr H; Jurecka W
    Acta Derm Venereol; 1982; 62(1):89-91. PubMed ID: 6175154
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of arsenical keratosis with etretinate.
    Sharma SC; Simpson NB
    Acta Derm Venereol; 1983; 63(5):449-52. PubMed ID: 6197851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.